Paper39207152
The fungal natural product fusidic acid demonstrates potent activity against Mycoplasma genitalium.
Wood GE and 7 others. Antimicrob Agents Chemother, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. The fungal natural product fusidic acid demonstrates potent activity against Mycoplasma genitalium. Papers, record 39207152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39207152
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The fungal natural product fusidic acid demonstrates potent activity against Mycoplasma genitalium.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mycoplasma genitalium | Major topic |
| Fusidic Acid | Major topic |
| Microbial Sensitivity Tests | Major topic |
| Anti-Bacterial Agents | Major topic |
| Humans | |
| Drug Resistance, Bacterial | |
| Biological Products | |
| Ascomycota | |
| Female | |
| Mycoplasma Infections |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R21 AI153863 | NIAID NIH HHS | United States | R21AI153863 | PubMed and NIH |
| R21AI153863 | HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) | R21AI153863 | PubMed and NIH |
Source NIH RePORTER
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12499185 | In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/12499185 | PubMed |
| 2 | 36984696 | 3-Amino-Substituted Analogues of Fusidic Acid as Membrane-Active Antibacterial Compounds. | Membranes (Basel) | 2023 | https://conductscience.org/library/papers/36984696 | PubMed |
| 3 | 34406799 | Azithromycin and Doxycycline Resistance Profiles of U.S. Mycoplasma genitalium Strains and Their Association with Treatment Outcomes. | J Clin Microbiol | 2021 | https://conductscience.org/library/papers/34406799 | PubMed |
| 4 | 34716226 | Nonantimicrobial Actions of Macrolides: Overview and Perspectives for Future Development. | Pharmacol Rev | 2021 | https://conductscience.org/library/papers/34716226 | PubMed |
| 5 | 37402645 | Mycoplasma genitalium in the US (MyGeniUS): Surveillance Data From Sexual Health Clinics in 4 US Regions. | Clin Infect Dis | 2023 | https://conductscience.org/library/papers/37402645 | PubMed |
| 6 | 18832309 | Interaction of Mycoplasma genitalium with host cells: evidence for nuclear localization. | Microbiology (Reading) | 2008 | https://conductscience.org/library/papers/18832309 | PubMed |
| 7 | 37272807 | Enterococcus faecalis OG1RF Evolution at Low pH Selects Fusidate-Sensitive Mutants in Elongation Factor G and at High pH Selects Defects in Phosphate Transport. | Appl Environ Microbiol | 2023 | https://conductscience.org/library/papers/37272807 | PubMed |
| 8 | 841314 | Pathogenic mycoplasmas: cultivation and vertebrate pathogenicity of a new spiroplasma. | Science | 1977 | https://conductscience.org/library/papers/841314 | PubMed |
| 9 | 16757601 | Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. | J Clin Microbiol | 2006 | https://conductscience.org/library/papers/16757601 | PubMed |
| 10 | 21221095 | Integrative genomics viewer. | Nat Biotechnol | 2011 | https://conductscience.org/library/papers/21221095 | PubMed |
| 11 | 19505943 | The Sequence Alignment/Map format and SAMtools. | Bioinformatics | 2009 | https://conductscience.org/library/papers/19505943 | PubMed |
| 12 | 11309125 | Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. | Mol Microbiol | 2001 | https://conductscience.org/library/papers/11309125 | PubMed |
| 13 | 27872239 | Experimental Infection of Pig-Tailed Macaques (Macaca nemestrina) with Mycoplasma genitalium. | Infect Immun | 2017 | https://conductscience.org/library/papers/27872239 | PubMed |
| 14 | 19602269 | Intracellular Mycoplasma genitalium infection of human vaginal and cervical epithelial cells elicits distinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage-mediated killing. | BMC Microbiol | 2009 | https://conductscience.org/library/papers/19602269 | PubMed |
| 15 | 29659762 | Activation of σ20-dependent recombination and horizontal gene transfer in Mycoplasma genitalium. | DNA Res | 2018 | https://conductscience.org/library/papers/29659762 | PubMed |
| 16 | 37070857 | In Vitro Susceptibility and Resistance of Mycoplasma genitalium to Nitroimidazoles. | Antimicrob Agents Chemother | 2023 | https://conductscience.org/library/papers/37070857 | PubMed |
| 17 | 33522241 | Synthesis of Fusidic Acid Derivatives Yields a Potent Antibiotic with an Improved Resistance Profile. | ACS Infect Dis | 2021 | https://conductscience.org/library/papers/33522241 | PubMed |
| 18 | 8849240 | Insusceptibility of members of the class Mollicutes to rifampin: studies of the Spiroplasma citri RNA polymerase beta-subunit gene. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8849240 | PubMed |
| 19 | 7791207 | Antibiotic susceptibility of Mycoplasma fermentans strains from various sources and the development of resistance to aminoglycosides in vitro. | J Med Microbiol | 1995 | https://conductscience.org/library/papers/7791207 | PubMed |
| 20 | 3887399 | UGA is read as tryptophan in Mycoplasma capricolum. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/3887399 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41918849 | The Role of Antimicrobial Susceptibility and Resistance Testing for Mycoplasma genitalium in Clinical Care. | Open Forum Infect Dis | 2026 | https://conductscience.org/library/papers/41918849 | PubMed |
| 41914618 | In vitro selection and characterization of resistance to pristinamycin in Mycoplasma genitalium. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/41914618 | PubMed |
| 40827472 | Mechanisms of fusidic acid resistance. | Biochem Soc Trans | 2025 | https://conductscience.org/library/papers/40827472 | PubMed |
| 40401977 | Automated Mycoplasma genitalium molecular macrolide resistance detection and nucleic acid target semi-quantitation: patient demographic considerations. | Microbiol Spectr | 2025 | https://conductscience.org/library/papers/40401977 | PubMed |
| 40363790 | Multi-Modal Design, Synthesis, and Biological Evaluation of Novel Fusidic Acid Derivatives. | Molecules | 2025 | https://conductscience.org/library/papers/40363790 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39207152
GET https://conductscience.org/api/papers/v1/39207152/references?page=2